Clinical Trial Update: Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating feasibility of neo-adjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma

Snippet

Sponsor: The European Uro-Oncology Group | Conditions: Upper Tract Urothelial Carcinoma | Phase 2 | Status: UNKNOWN